Portfolio company
CinCor Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
Digital Health
About
This biopharmaceutical company develops aldosterone synthase inhibitors to treat patients with resistant hypertension and chronic kidney disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.